Codexis Forward-Looking Statement This press release contains forward-looking statements relating to the benefits of the novel biocatalytic method for the synthesis of sitagliptin and the future ...

In 2010 two US pharmaceutical companies created a variant of an R-ATA allowing industrial-scale synthesis of sitagliptin, a medicine for type-2 diabetes. The improved enzyme gave a 53% increase in ...

The process improvements in the sitagliptin synthesis were recognized by the US Environmental Protection Agency's 2010 Presidential Green Chemistry Challenge Awards. The earlier manufacturing process ...

Codexis Forward-Looking Statement This press release contains forward-looking statements relating to the benefits of the novel biocatalytic method for the synthesis of sitagliptin and the future ...